106157-82-8 Usage
General Description
Ethanone, 1-(2-amino-4-pyrimidinyl)- is a chemical compound with the molecular formula C7H8N4O. It is a ketone compound with an attached pyrimidine ring, and it contains an amino group at the second carbon position of the pyrimidine ring. Ethanone,1-(2-amino-4-pyrimidinyl)- may have potential applications in various chemical and pharmaceutical processes, possibly in the synthesis of other organic compounds or as a component in medicinal or agricultural products. Its specific properties and uses would depend on the context and the intended application in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 106157-82-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,1,5 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 106157-82:
(8*1)+(7*0)+(6*6)+(5*1)+(4*5)+(3*7)+(2*8)+(1*2)=108
108 % 10 = 8
So 106157-82-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3O/c1-4(10)5-2-3-8-6(7)9-5/h2-3H,1H3,(H2,7,8,9)
106157-82-8Relevant articles and documents
AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS
-
Page/Page column 23-24, (2011/07/09)
The invention relates to amino-heteroaryl derivatives having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of these derivatives for the treatment of pain, such as neuropathic pain or inflammatory pain.
N-substituted pyrrolopyridinones active as kinase inhibitors
-
Page/Page column 19, (2010/11/27)
Compounds represented by formula (I) wherein A, R1, R2, R3, R4, R5, and R6 are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
PYRIMIDYLPYRROLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
-
Page/Page column 24; 25, (2010/02/10)
Pyrimidylpyrrole derivatives of formula (1) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be